Phio Pharmaceuticals Corp (PHIO)

Finanzdaten der Phio Pharmaceuticals Corp-Aktie (PHIO)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	16.32% 2.209	1.899	2.776	2.547	3.602
Operating Income/Loss	16.32% -2.209	-1.899	-2.776	-2.547	-3.602
Nonoperating Income/Loss	1,275% 0.055	0.004	-0.004	-0.002	-
Income/Loss From Continuing Operations Before Tax	13.67% -2.154	-1.895	-2.78	-2.549	-3.602
Income/Loss From Continuing Operations After Tax	13.67% -2.154	-1.895	-2.78	-2.549	-3.602
Net Income/Loss	13.67% -2.154	-1.895	-2.78	-2.549	-3.602
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1,385% 4.5801	0.3085	2.4402	1,728.49	1.1422
Diluted Average Shares	1,385% 4.5801	0.3085	2.4402	1,728.49	1.1422
Basic Earnings Per Share	176.47% -0.47	-0.17	-1.14	-1.47	-3.15
Diluted Earnings Per Share	176.47% -0.47	-0.17	-1.14	-1.47	-3.15
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-